Diabetes Technology & Therapeutics

1. Diabetes Technol Ther10 Jun 2026

   Early Assessment of Teplizumab Treatment Response Using Continuous Glucose Monitoring

   Cohort studyT1D

2. Diabetes Technol Ther10 Jun 2026

   First Use of Control-IQ+ Technology in Newly Indicated Populations

   Cohort studyTechnology

3. Diabetes Technol Ther8 Jun 2026

   Temporary Target Use with Automated Insulin Delivery Is Associated with Longer and Safer Exercise in Adolescents with Type 1 Diabetes: A Post Hoc Analysis from the Fast Advanced Closed-Loop Therapy Study

   Secondary analysisTechnology

4. Diabetes Technol Ther8 Jun 2026

   Glycemic Responses to Two Different Exercise Modalities in Adolescents with Type 1 Diabetes Using Automated Insulin Delivery Systems: The AIDing Exercise Study

   Randomized controlled trialTechnology

5. Diabetes Technol Ther5 Jun 2026

   Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe Use

   Guideline or statementT1D

6. Diabetes Technol Ther1 Jun 2026

   Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes: Outcomes of a Population-Based Real-World Study

   Cohort studyDiabetes in pregnancy

7. Diabetes Technol Ther28 May 2026

   Increased Glycation Ratio and Risk of Complications in Latent Autoimmune Diabetes in Adults Compared With Type 1 Diabetes Onset before 30 Years: A Cohort Study

   Cross-sectional studyT1D

8. Diabetes Technol Ther21 May 2026

   Glycemic Concordance of Simplera Sync ™ and Instinct ™ Sensors in MiniMed ™ 780G System Users: A Randomized Crossover Feasibility Study

   Randomized controlled trialTechnology

9. Diabetes Technol Ther20 May 2026

   Glycemic Outcomes and Device Engagement Over 18 Months Following Initiation of Two Different Automated Insulin Delivery Systems in American Youth With Type 1 Diabetes

   Cohort studyTechnology

10. Diabetes Technol Ther12 May 2026

    Real-World Total Daily Insulin Dose in over 14,000 Young Individuals with Type 1 Diabetes in the United States

    Cohort studyT1D

11. Diabetes Technol Ther11 May 2026

    Real-World Ketone Testing Patterns Among People Using FreeStyle Libre

    Cohort studyTechnology

12. Diabetes Technol Ther7 May 2026

    Cardiovascular, Renal, and Hepatic Biomarkers Outside Guideline-Recommended Thresholds: Prevalence and Determinants in Type 1 Diabetes

    Cohort studyComplications

13. Diabetes Technol Ther2 May 2026

    Real-World Impact of a National Funding-Driven Transition Between Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes

    Cohort studyTechnology

14. Diabetes Technol Ther28 Apr 2026

    Safety and Effectiveness of MiniMed TM 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes

    Research articleTechnology

15. Diabetes Technol Ther17 Apr 2026

    Operational and Clinical Insights from a Fully Decentralized Clinical Study Evaluating Protocol Adherence, Participant Satisfaction, and Connected Device Data in Individuals with Type 2 Diabetes on Different Treatment Regimens

    Cohort studyT2D & other

16. Diabetes Technol Ther14 Apr 2026

    Continuous Glucose Monitoring in Insulin-Treated Type 2 Diabetes Mellitus in Sweden: A Scoping Review and Policy Landscape Analysis

    Research articleTechnology

17. Diabetes Technol Ther12 Apr 2026

    MiniMed TM 780G System Users Achieve Similar Glycemic Outcomes Regardless of Socioeconomic Disadvantage

    Cohort studyTechnology

18. Diabetes Technol Ther7 Apr 2026

    Early Initiation of Automated Insulin Delivery at Type 1 Diabetes Diagnosis in Children and Adolescents Is Associated with Improved Outcomes

    Cohort studyTechnology

19. Diabetes Technol Ther25 Mar 2026

    Quality-Score (Q-Score) Can Be More Sensitive than %Time in Range and Several Other CGM Metrics in Detecting Responses to Therapeutic Interventions

    Cohort studyTechnology

20. Diabetes Technol Ther23 Mar 2026

    Continuous Glucose Monitoring Identifies Youth with Prediabetes at Risk for Glycemic Progression

    Cohort studyT2D & other

21. Diabetes Technol Ther19 Mar 2026

    Ultrasound-Guided Infusion Site Rotation Improves Glycemic Outcomes in Children and Adolescent Users of Automated Insulin Delivery Systems

    Cohort studyTechnology

22. Diabetes Technol Ther16 Mar 2026

    The Virtual Diabetes Control and Complications Trial #4: Relationship of HbA1c and Continuous Glucose Monitoring Metrics with Severe Hypoglycemic Events

    Secondary analysisTechnology

23. Diabetes Technol Ther14 Mar 2026

    Clinical Efficacy Evaluation of a Continuous Glucose Monitoring-Guided Forecasting Algorithm to Mitigate Postbariatric Hypoglycemia: A Randomized Controlled Trial

    Randomized controlled trialObesity

24. Diabetes Technol Ther14 Mar 2026

    Inhaled Technosphere Insulin Reduces Postmeal Glucose Excursion in Youth Living with Type 1 Diabetes

    Secondary analysisT1D

25. Diabetes Technol Ther10 Mar 2026

    Continuous Glucose Monitoring Metrics Using FreeStyle Libre3 in Patients with Type 2 Diabetes and Gastroparesis: A Pilot Prospective Investigator-Initiated Study

    Cohort studyTechnology

26. Diabetes Technol Ther10 Mar 2026

    Glucose Control and Continuous Glucose Monitoring Metrics During 12 Months of Treatment with Tirzepatide in Overweight or Obese Patients with Type 1 Diabetes

    Case-control studyT1D

27. Diabetes Technol Ther10 Mar 2026

    Patient-Reported Adverse Events with Adjunctive Tirzepatide or Semaglutide Treatment in Adults with Type 1 Diabetes

    Cross-sectional studyT1D

28. Diabetes Technol Ther9 Mar 2026

    Continuous Ketone Monitoring in Diabetic Ketoacidosis: Prospective Multicenter Method-Comparison and Feasibility Study

    Cohort studyT1D

29. Diabetes Technol Ther5 Mar 2026

    Extended Use of Automated Insulin Delivery in Young People with Type 1 Diabetes and Elevated HbA1c: 52-Week Outcomes of the CO-PILOT Trial

    Randomized controlled trialTechnology

30. Diabetes Technol Ther1 Mar 2026

    Impact of Continuous Glucose Monitor on Health Care Resource Utilization in Adults with Type 2 Diabetes Managed by Noninsulin Therapies

    Cohort studyTechnology

31. Diabetes Technol Ther17 Feb 2026

    Intermittently Scanned Continuous Glucose Monitoring Enhances Weight Loss and Adherence in Women with Obesity: A Randomized Controlled Trial

    Randomized controlled trialObesity

32. Diabetes Technol Ther17 Feb 2026

    Accuracy of Dexcom G6® and FreeStyle Libre® Sensors in Standardized Hypoxia Conditions: A Randomized Controlled Trial—FOX Study

    Randomized controlled trialTechnology

33. Diabetes Technol Ther17 Feb 2026

    Optimizing Diabetes Management During Type 1 Diabetes Pregnancy with Automated Insulin Delivery Therapy: Clinical Impact and Economic Consequences in Spain

    Research articleDiabetes in pregnancy

34. Diabetes Technol Ther16 Feb 2026

    Accuracy of Real-Time Continuous Glucose Monitoring System in Hospitalized Patients with Diabetes and Chronic Kidney Disease

    Cohort studyTechnology

35. Diabetes Technol Ther12 Feb 2026

    Glycemic Outcomes During Outpatient Use of Automated Insulin Delivery Without Meal Announcement in Adults with Type 1 Diabetes: Results from the CLOSE IT Randomized Controlled Trial

    Randomized controlled trialTechnology

36. Diabetes Technol Ther12 Feb 2026

    Ketone Profiles in Community-Dwelling Adults with Type 1 Diabetes Using Continuous Ketone Monitoring

    Cohort studyT1D

37. Diabetes Technol Ther11 Feb 2026

    Accuracy of a Continuous Glucose Monitor in the Intensive Care Unit

    Diagnostic or prognostic studyTechnology

38. Diabetes Technol Ther11 Feb 2026

    Subcutaneous Catheter Type and Wear Duration in Automated Insulin Delivery Systems: Associations with Glycemic Control in Patients Living with Type 1 Diabetes

    Cohort studyTechnology

39. Diabetes Technol Ther9 Feb 2026

    Real-World Performance of the MiniMed 780G Advanced Hybrid Closed-Loop System in the Middle East, North Africa, and Türkiye Region

    Cohort studyTechnology

40. Diabetes Technol Ther6 Feb 2026

    Safety and Feasibility of Algorithmic Continuous Glucose Monitoring-Based Titration in People with Type 2 Diabetes Using Insulin Degludec, With or Without Noninsulin Glucose-Lowering Drugs: A 16-Week Randomized Controlled Trial

    Randomized controlled trialTechnology

All 475 Briefs in ExploreShowing Briefs 41–80 of 475, newest first